.Merck defeats earnings assumptions, brings up purchases overview on powerful demand for leading medicines like Keytruda CNBCMerck & Co. (MRK US) Trumps Earnings Projections as Keytruda Purchases Increase BloombergMerck Inventory: Pharma Giant Posts Strong Results, Yet Outlook Falls Short Financier's Company DailyMerck Announces Second-Quarter 2024 Financial Outcomes Yahoo FinanceMerck defeats revenue as well as sales requirements among Keytruda asset, yet supplies combined full-year expectation MarketWatch.